Suspended NA INTERVENTIONAL 1-arm NCT04683120

Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics

Sponsor: Laser LabCorp

Conditions Breast Cancer Cancer Diagnosis Margins of Excision Margins, Tumor-Free Oncology

Updated 6 times since 2021 Last updated: Jun 26, 2021 Started: Dec 15, 2021 Primary completion: Aug 3, 2022 Completion: Nov 2, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

New Medical Team and Surgical Center Location

This NA trial investigates Breast Cancer and Cancer Diagnosis and is currently suspended. Laser LabCorp leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Suspended NA
Jul 2024 — Sep 2024 [monthly]

Suspended NA
Sep 2021 — Jul 2024 [monthly]

Suspended NA

Status: Not Yet Recruiting → Suspended
Apr 2021 — Sep 2021 [monthly]

Not Yet Recruiting NA
Mar 2021 — Apr 2021 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Jan 2021 — Mar 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Laser LabCorp

Data source: Laser LabCorp

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States